• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Realignment lay offs





Remember the famous words uttered by the dishonest ones in Dallas last fall " We're looking to get bigger not smaller" but as evidenced by the displacement of most of the Synergy team.. total B.S !!
 








Not really, no one know the BMS purchase was coming, since most of the Synergy folks had been around in pharma for a long time most had no real interest in joining the big pharma stew of BMS/AZ.